Paper8943097
Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells.
Vrionis FD and 4 others. J Neurooncol, 1996. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells. Papers, record 8943097. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8943097
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinosarcoma | Major topic |
| Genetic Therapy | Major topic |
| Simplexvirus | Major topic |
| Thymidine Kinase | Major topic |
| Animals | |
| Antiviral Agents | |
| Blotting, Western | |
| Cell Survival | |
| Cell Transformation, Viral | |
| Ganciclovir | |
| Gene Expression Regulation, Neoplastic | |
| Gene Expression Regulation, Viral | |
| Injections, Spinal | |
| Plasmids | |
| Rats | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30DK 34928 | NIDDK NIH HHS | United States | P30DK034928 | PubMed and NIH |
Source NIH RePORTER
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3019523 | Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. | Cancer Res | 1986 | https://conductscience.org/library/papers/3019523 | PubMed |
| 2 | 8380127 | In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. | Cancer Res | 1993 | https://conductscience.org/library/papers/8380127 | PubMed |
| 3 | 8221662 | The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. | Cancer Res | 1993 | https://conductscience.org/library/papers/8221662 | PubMed |
| 4 | 3685260 | Computer programs for the analysis of cellular survival data. | Radiat Res | 1987 | https://conductscience.org/library/papers/3685260 | PubMed |
| 5 | 8384892 | Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. | Hum Gene Ther | 1993 | https://conductscience.org/library/papers/8384892 | PubMed |
| 6 | 1423266 | Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. | Cancer Res | 1992 | https://conductscience.org/library/papers/1423266 | PubMed |
| 7 | 8391069 | An experimental model of retrovirus gene therapy for malignant brain tumors. | J Neurosurg | 1993 | https://conductscience.org/library/papers/8391069 | PubMed |
| 8 | 1317968 | In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. | Science | 1992 | https://conductscience.org/library/papers/1317968 | PubMed |
| 9 | 1450408 | Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. | Blood | 1992 | https://conductscience.org/library/papers/1450408 | PubMed |
| 10 | 8186287 | In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. | Hum Gene Ther | 1993 | https://conductscience.org/library/papers/8186287 | PubMed |
| 11 | 1335754 | Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines. | J Immunother (1991) | 1992 | https://conductscience.org/library/papers/1335754 | PubMed |
| 12 | 6315212 | Correlations between cytologic composition and biologic behavior in the glioblastoma multiforme. A postmortem study of 50 cases. | Cancer | 1983 | https://conductscience.org/library/papers/6315212 | PubMed |
| 13 | 8346212 | Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8346212 | PubMed |
| 14 | 2833027 | Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine kinase: effects on catalytic activity. | Virology | 1988 | https://conductscience.org/library/papers/2833027 | PubMed |
| 15 | 8592228 | Tumor cells expressing the herpes simplex virus-thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats. | J Neurosurg | 1996 | https://conductscience.org/library/papers/8592228 | PubMed |
| 16 | 8058777 | Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8058777 | PubMed |
| 17 | 1851332 | Experimental therapy of human glioma by means of a genetically engineered virus mutant. | Science | 1991 | https://conductscience.org/library/papers/1851332 | PubMed |
| 18 | 7954393 | Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. | Cancer Res | 1994 | https://conductscience.org/library/papers/7954393 | PubMed |
| 19 | 7923150 | Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. | Cancer Res | 1994 | https://conductscience.org/library/papers/7923150 | PubMed |
| 20 | 8183911 | Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8183911 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 11110418 | Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme. | Gene Ther | 2000 | https://conductscience.org/library/papers/11110418 | PubMed |
| 9696378 | Gene therapy of neoplastic meningosis. | J Neurooncol | 1998 | https://conductscience.org/library/papers/9696378 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8943097
GET https://conductscience.org/api/papers/v1/8943097/references?page=2